Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Retinas at Risk: Real-World Cases in High Disease Activity and Adherence Challenges
Carl D. Regillo, MD, FACS, FASRS
Lejla Vajzovic, MD, FASRS
Interpreting Gene Therapy Data With Confidence
Szilard Kiss, MD
Gene Therapy for nAMD: Focus on Future Readiness
Gene Therapy for nAMD: Navigating the Next Era of Durable Retinal Treatment
Seeing the Cornea Clearly
Jacob Lang
Uncovering the Drivers of Dry Eye Symptoms
Steve Jackson, PharmD
Anat Galor, MD, MSPH
Seeing the Signs of Dry Eye Disease
John D. Sheppard, MD
Geographic Atrophy: A Personalized Approach
Charles Turck, PharmD, BCPS, BCCCP
Jonathan Jonisch, MD
How Gene Therapy Is Designed to Work in Retinal Disease
Illuminating Patient Selection for PBM in AMD: A Case-Based Discussion
Diana V. Do, MD
David S. Boyer, MD
Eleonora Lad, MD, PhD
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Janis T. Eells, Ph.D.
David Boyer, MD
Marion R. Munk, MD, PhD
Redefining Durability in nAMD: The Science and Strategy of Sustained-Delivery TKIs
Ashkan Abbey, MD
Rishi Singh, MD, FASRS
Improving Early Detection of Geographic Atrophy
Alexandria May, PharmD, BCPS
Hasenin Al-khersan, MD
ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Michael A. Klufas, MD
Optimizing Anti-VEGF Selection in Diabetic Macular Edema
What's Next in Uveitis Care?
Steven Yeh, MD, FASRS
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.